NEW BRUNSWICK, N.J. -- Booster doses of Johnson & Johnson's one-shot coronavirus vaccine generated a big spike in antibodies, the frontline immune system defenses against infection, the company ...

NEW BRUNSWICK, N.J. - Johnson & Johnson said Tuesday it has asked the U.S. Food and Drug Administration to authorize a booster shot for its single-dose COVID-19 vaccine as the government looks to ...

NEW YORK (WABC) -- A CDC panel will meet this week to discuss recommendations for Moderna and Johnson and Johnson COVID-19 vaccine boosters. The meetings come after after an FDA advisory panel made ...

Johnson & Johnson said Wednesday that new data from early trials of a booster shot of its COVID-19 vaccine provides a "rapid and robust increase in spike-binding antibodies" that fight off the virus.

STANFORD, Calif. (KGO) -- As concerns grow over the slow pace of COVID-19 vaccinations in the U.S., there's hope that a new option could soon help turn the tide. The vaccine from Johnson & Johnson ...

Results from early stage trials of Johnson & Johnson’s COVID-19 vaccine are promising, showing the one-dose vaccine generates an immune response in nearly all volunteers, with minimal side effects.

Johnson & Johnson submitted its one-shot coronavirus vaccine for an emergency use authorization to the FDA on Thursday. While not fully as effective as the two-shot Pfizer and Moderna vaccines, ...

Johnson & Johnson announced Monday it could have a coronavirus vaccine ready for human testing by September. The company said it has selected a lead vaccine candidate from constructs it's been working ...

Nearly 4 million doses of Johnson & Johnson's single-dose COVID-19 vaccine are headed to states, including California, with injections expected to start as early as Tuesday. The White House says the ...